Despite declining age-standardized rates, lead-attributable cardiovascular disease burden remains substantial (approximately 1.48 million deaths and 30.0 million DALYs in 2021) and increasingly concentrated in lower-SDI populations, driven mainly by population growth and aging.
Key Findings
Results
Global age-standardized mortality and DALY rates for lead-attributable CVD declined from 1990 to 2021, but absolute burden remained high.
EAPC was -0.76%/year for age-standardized mortality rate (ASMR) and -1.09%/year for age-standardized DALY rate (ASDR) from 1990 to 2021.
Absolute burden in 2021 was approximately 1.48 million deaths and approximately 30.0 million DALYs.
Higher absolute counts were observed in males compared to females.
Data were extracted from GBD 2021 estimates covering the period 1990–2021.
Results
Socioeconomic development level was associated with differential rates of burden reduction, with low-SDI regions experiencing increasing deaths and DALYs.
High-SDI settings achieved the fastest rate reductions in ASMR and ASDR.
Low-SDI regions experienced increasing deaths and DALYs over the study period.
Low-SDI regions also showed slower declines in age-standardized rates compared to high-SDI regions.
Frontier analysis identified large efficiency gaps in many low- and middle-SDI countries, suggesting these countries perform below what would be expected for their SDI level.
Results
Population growth was the dominant driver of increasing lead-attributable CVD deaths and DALYs, partially offset by favorable epidemiologic change.
Das Gupta-type decomposition was applied to separate effects of population growth, aging, and epidemiologic change.
Population growth accounted for 96.07% of the increase in deaths and 131.44% of the increase in DALYs.
Favorable epidemiologic change offset -43.19% of deaths and -78.83% of DALYs.
Aging was also identified as a contributing driver alongside population growth.
Results
Socioeconomic inequality in lead-attributable CVD burden widened between 1990 and 2021.
The slope index of inequality (SII) for ASMR changed from -2.62 to -7.15 between 1990 and 2021, indicating widening absolute inequality.
The SII for ASDR changed from -70.24 to -144.88 over the same period.
Concentration indices became more negative from 1990 to 2021, indicating that burden became increasingly concentrated among lower-SDI populations.
Inequality was assessed using both slope index of inequality and concentration index methods.
Results
Projections using ARIMA models indicate continued declines in age-standardized rates of lead-attributable CVD through 2040.
ARIMA models were used to project ASMR and ASDR to 2040.
Both ASMR and ASDR are projected to continue declining through 2040.
Despite projected rate declines, the authors note that absolute burden may remain substantial due to population growth and aging.
Projections were based on GBD 2021 data spanning 1990–2021.
Methods
GBD 2021 data covering 1990–2021 were analyzed using multiple analytical approaches to characterize lead-attributable CVD burden.
Outcomes included deaths, DALYs, and age-standardized rates (ASMR/ASDR) stratified by sex, SDI quintile, region, and country.
Temporal trends were summarized using estimated annual percentage change (EAPC).
Das Gupta-type decomposition was applied to separate population growth, aging, and epidemiologic change.
Inequality was assessed using slope index of inequality (SII) and concentration index; efficiency gaps were evaluated via SDI-based frontier analysis using LOESS smoothing.
Lin Z, Zhang Z, Zeng Q, Luo S, Xu J. (2026). Global burden of cardiovascular disease attributable to lead exposure: based on the global burden of disease study 2021.. Frontiers in public health. https://doi.org/10.3389/fpubh.2026.1690287